The German Federal Institute for Drugs and Medical Devices (BfArM) on Monday announced the final results of the domestic cultivation application process, confirming the preliminary results as reported by Marijuana Business Daily last month.
Months after the initial process was derailed by lawsuits, the German Federal Institute for Drugs and Medical Devices (BfArM) reissued the country’s first tender bid to cultivate and process medical cannabis domestically.
The Netherlands has agreed to significantly increase shipments of medical cannabis to Germany to help the country cope with soaring demand.
Germany restarted the application process to grow medical cannabis in the country, but the amount called for remains well short of anticipated demand.
